Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
6407 ARTÍCULOS , VIENDO DEL 1936 AL 1950
Parkin Pleiotropy: Extremely Atypical Phenotypes in Patients With Compound Heterozygous Mutations
Millar Vernetti P, Rossi M, Merello M.
Tremor Other Hyperkinet Mov (N Y). 2020 Aug 13;10:26. doi: 10.5334/tohm.55.
van der Heide A, Meinders MJ, Bloem BR, Helmich RC.
J Parkinsons Dis. 2020;10(4):1355-1364. doi: 10.3233/JPD-202251.
[Magnetic resonance tomography controlled focused ultrasound (MRgFUS) for tremor]
Wüllner U.
Fortschr Neurol Psychiatr. 2020 Sep;88(9):582-585. doi: 10.1055/a-1227-6211. Epub 2020 Sep 21.
Parkinson's Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis?
Shah P, Sagar PR, Alhumaidi N, Bollampally VC, Malik BH.
Cureus. 2020 Aug 22;12(8):e9933. doi: 10.7759/cureus.9933.
Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
Wang XX, Feng Y, Li X, Zhu XY, Truong D, Ondo WG, Wu YC.
Front Neurol. 2020 Aug 25;11:874. doi: 10.3389/fneur.2020.00874. eCollection 2020.
The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols
Aryal S, Skinner T, Bridges B, Weber JT.
Molecules. 2020 Sep 24;25(19):4382. doi: 10.3390/molecules25194382.
A Deep Brain Stimulation Trial Period for Treating Chronic Pain
Shirvalkar P, Sellers KK, Schmitgen A, Prosky J, Joseph I, Starr PA, Chang EF.
J Clin Med. 2020 Sep 29;9(10):3155. doi: 10.3390/jcm9103155.
Lu R, Xu Y, Li X, Fan Y, Zeng W, Tan Y, Ren K, Chen W, Cao X.
Parkinsons Dis. 2020 Sep 23;2020:4693019. doi: 10.1155/2020/4693019. eCollection 2020.
Sleep Issues in Parkinson's Disease and Their Management
Zuzuárregui JRP, During EH.
Neurotherapeutics. 2020 Oct;17(4):1480-1494. doi: 10.1007/s13311-020-00938-y. Epub 2020 Oct 7.
Arylsulfatase A (ASA) in Parkinson's Disease: From Pathogenesis to Biomarker Potential
Angelopoulou E, Paudel YN, Villa C, Piperi C.
Brain Sci. 2020 Oct 7;10(10):713. doi: 10.3390/brainsci10100713.
Parkinsonism in Patients with Neuronopathic (Type 3) Gaucher Disease: A Case Series
Ryan E, Amato D, MacKenzie JJ, Sidransky E, Lopez G.
Mov Disord Clin Pract. 2020 Aug 17;7(7):834-837. doi: 10.1002/mdc3.13031. eCollection 2020 Oct.
History of and Insights Into Spinal Cord Stimulation in Parkinson Disease
Garcia BB, Junior ER, Araújo MFP, Simplício H.
Neurorehabil Neural Repair. 2020 Nov;34(11):967-978. doi: 10.1177/1545968320956984. Epub 2020 Oct 13.
Davis G, Levine Z.
Stereotact Funct Neurosurg. 2021;99(1):38-39. doi: 10.1159/000510122. Epub 2020 Oct 16.
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease
Prasad EM, Hung SY.
Antioxidants (Basel). 2020 Oct 16;9(10):1007. doi: 10.3390/antiox9101007.
Current and emerging therapeutic targets for Parkinson's disease
Pingale T, Gupta GL.
Metab Brain Dis. 2021 Jan;36(1):13-27. doi: 10.1007/s11011-020-00636-w. Epub 2020 Oct 22.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.